Intrexon Corporation Organizes Around New Synthetic Biology Markets
5/10/2013 9:24:48 AM
More...
|
Soligenix (SNGX.OB) and Intrexon Corporation Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
5/1/2013 10:19:51 AM
More...
|
Synthetic Biologics, Inc. (AEN) Reiterates that the Infectious Disease Collaboration With Intrexon Corporation Remains in Effect
4/22/2013 10:08:43 AM
More...
|
AmpliPhi Biosciences (TGEN) Establishes Collaboration With Intrexon Corporation
4/16/2013 9:34:08 AM
More...
|
Oragenics, Inc. (OGEN)-Intrexon Corporation Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140
2/12/2013 9:49:36 AM
More...
|
Sanford-Burnham Medical Research Institute and Intrexon Corporation Establish Collaboration to Accelerate Stem Cell Research
1/3/2013 11:01:40 AM
More...
|
Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Initiate Development of Monoclonal Antibodies for Whooping Cough (Pertussis)
12/21/2012 8:30:37 AM
More...
|
Scheer Partners, Inc. Represents Biotech Company Intrexon Corporation in 55,000-Square-Foot Lease of Lab and Office Space in Germantown
10/22/2012 11:00:21 AM
More...
|
Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
8/8/2012 7:58:04 AM
More...
|
Experienced Life Sciences Executive to Intrexon Corporation as Chief Operating Officer
12/5/2011 9:16:38 AM
More...
|
|